Acumen Pharmaceuticals (ABOS) Non Operating Income (2020 - 2026)
Acumen Pharmaceuticals' Non Operating Income came in at -$162,000 for Q2 2026, compared with $800,000 a year earlier.
Acumen Pharmaceuticals (ABOS) Non Operating Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Acumen Pharmaceuticals reported Non Operating Income of $373,000, down 94.9% year-over-year; for FY2025, it came in at $2.5 million, down 78.6% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $11.69 million in FY2024 (+33.3%), $8.77 million in FY2023 (+268.2%), $2.38 million in FY2022 and -$81.02 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q2 2021.
- Year-over-year, Non Operating Income increased in 1 of the last seven quarters, with an average decline of 55.7%.
- The fastest year-over-year change in Non Operating Income over five years came in Q2 2023 (growth of 618.5%), and the weakest in Q3 2025 (a decline of 97.5%).
- Business Quant data shows ABOS's Non Operating Income at $412,000 (Q1 2026), $61,000 (Q4 2025) and $62,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Acumen Pharmaceuticals | 160.54 Mn | 160.54 Mn | - | -162,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -162,000.00 |
| Mar 31, 2026 | 412,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 661,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 33,000.00 |
Acumen Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();